Get startedLog in
    Picture of Chosa Oncology AB logo

    CHOSA — Chosa Oncology AB News Story

    0.000.00%
    se flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro CapSucker Stock
    All News

    Brief: RhoVac Receives Approval In Finland To Start Clinical Phase IIb Study In Prostate Cancer

    Picture of Chosa Oncology AB logoChosa Oncology AB
    29/10/2019 08:35
    Oct 29 (Reuters) - RhoVac AB  RHOVAC.TE :
    * RHOVAC RECEIVES APPROVAL IN FINLAND TO START CLINICAL
PHASE IIB
STUDY IN PROSTATE CANCER
    * RESULTS REPORTING ON PRIMARY OBJECTIVE OF STUDY IS
EXPECTED
DURING H2 2021

Source text for Eikon:  ID:nWkr72Ksh2 
Further company coverage:  RHOVAC.TE 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))

    Recent news on Chosa Oncology AB

    See all news